3 billion large varieties were looted, Guangzhou pharmaceutical companies are about to be approved

Recently, another company will enter the PPI large variety lansoprazole

Figure 1: The registration progress of lansoprazole for injection of Poinsettia

Source: NMPA official website

Lansoprazole is the first-generation PPI preparation, and its bioavailability is 30% higher than that of omeprazole, and it inhibits gastric acid secretion by 2-10 times

Figure 2: The formulation of Lansoprazole

Source: Mi Nei.

At present, the products involved in Lansoprazole include enteric-coated capsules, capsules, ordinary tablets, orally disintegrating tablets, and enteric-coated tablets.

Figure 3: The situation of companies that have been reviewed/deemed to have reviewed lansoprazole for injection

Source: Mi Nei Net Consistency Evaluation Database

There are more than 30 domestic companies with approvals for lansoprazole for injection, but only 6 companies have been reviewed.

Source: NMPA official website, Minet database

The review data statistics are as of November 2.